Responses
Other responses
Jump to comment:
- Published on: 12 February 2013
- Published on: 7 February 2013
- Published on: 12 February 2013Herpes zoster infection risk in patients with rheumatoid arthritis on tumor necrosis factor inhibitors Prabha Ranganathan MD, MSShow More
Dear Editor,
We read with interest the study conducted by Galloway and colleagues on the risk of skin and soft tissue infections (SSTI) and herpes zoster (HZ) in patients with rheumatoid arthritis (RA) treated with tumor necrosis factor (TNF) antagonists versus non-biologic disease-modifying anti-rheumatic drugs (nbDMARDs). (1) This study highlights the occurrence of common infections such as SSTI and more unco...
Conflict of Interest:
None declared. - Published on: 7 February 2013TNF antagonists and Shingles: Is Vaccination Advisable?Show More
Dear Editor,
We read with interest the report by Galloway et al on the risk of skin and soft tissue infections (including shingles) in patients exposed to TNF antagonists from the BSRBR [1]. In the light of our recently published systematic literature review of the risk of shingles in rheumatoid arthritis (RA) patients, we would like to address several issues raised in the report [2]. The authors state that the inci...
Conflict of Interest:
None declared.